Thirty Madison Real Customer Outcomes: An Evidence-Based Review

What Is Thirty Madison and How Does It Work?

Thirty Madison is a direct-to-consumer telehealth holding company that operates condition-specific brands rather than a single generalist platform. Each subsidiary focuses on one clinical area: Keeps handles androgenetic alopecia, Cove manages migraine, Picnic covers allergic rhinitis, and Facet addresses dermatologic concerns including acne and aging.

The consultation model is asynchronous. Patients complete an intake questionnaire, upload relevant photos (for hair loss and dermatology), and a licensed provider reviews the submission within 24 to 48 hours. Prescriptions ship from partner pharmacies, typically arriving within 5 to 7 business days. Follow-up visits occur every 3 to 12 months depending on the condition and medication.

This differs from synchronous telehealth platforms like Hims, Ro, or PlushCare, where patients typically join a live video or phone appointment. The tradeoff: asynchronous visits are cheaper and faster to schedule, but patients lose the real-time dialogue that can surface nuanced symptoms. A 2023 cross-sectional study of direct-to-consumer telehealth platforms found that asynchronous dermatology consultations had diagnostic concordance rates of 83% compared to 91% for synchronous video visits [1]. The gap narrows for straightforward pattern recognition conditions like male-pattern baldness.

Thirty Madison raised over $140 million in venture funding through Series C and acquired Cove in 2021. The company is not publicly traded.

Keeps (Hair Loss): What the Clinical Data Actually Shows

Keeps prescribes two FDA-approved medications for androgenetic alopecia: oral finasteride 1 mg daily and topical minoxidil 5% solution or foam. These are not proprietary formulations. They are the same generic drugs available at any pharmacy.

The efficacy data is strong. A 5-year extension of the original finasteride Phase III trial showed that 65% of men taking finasteride 1 mg daily experienced increased hair count at 5 years compared to baseline, while the placebo group continued to lose hair [2]. Minoxidil 5% produces visible regrowth in approximately 40% of men and slows further loss in another 40% after 48 weeks of use, per a randomized trial published in the Journal of the American Academy of Dermatology [3].

Customer reviews on Trustpilot give Keeps a 4.0/5 composite across roughly 8,000 reviews. The most common positive themes: convenience of home delivery, responsive customer service, and visible hair stabilization within 4 to 6 months. Negative reviews cluster around three issues: auto-renewal billing confusion (accounting for roughly 22% of 1-star reviews), delayed shipping, and unmet expectations about regrowth speed.

One pattern in negative Keeps reviews deserves clinical context. Multiple reviewers report "the drug didn't work" after 8 to 12 weeks of use. Finasteride requires a minimum of 3 months to slow hair loss and 6 to 12 months to produce visible regrowth [4]. Any platform selling finasteride faces this expectation gap. It is not unique to Keeps.

Side effect concerns. The FDA label for finasteride 1 mg lists decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7% placebo), and decreased ejaculate volume (0.8% vs. 0.4% placebo) based on the original registration trials [5]. The "post-finasteride syndrome" hypothesis remains controversial. A 2023 systematic review in Andrology found no consistent evidence of persistent sexual side effects after drug discontinuation, though the authors noted that most studies had methodological limitations and called for larger prospective trials [6].

Cove (Migraine): Prescription Options and Reported Outcomes

Cove prescribes both acute and preventive migraine medications. The acute formulary includes sumatriptan (25 to 100 mg oral), rizatriptan (5 to 10 mg ODT), and ubrogepant (Ubrelvy). Preventive options include topiramate (25 to 100 mg daily), propranolol (40 to 160 mg daily), amitriptyline, and, in some cases, CGRP-targeting agents like rimegepant (Nurtec ODT) for dual acute/preventive use.

The clinical evidence behind these drugs is not in question. Sumatriptan produces 2-hour pain freedom in 28 to 32% of episodic migraine attacks versus 11 to 15% for placebo across multiple randomized controlled trials [7]. Topiramate reduces monthly migraine days by a median of 1.4 to 2.0 days compared to placebo at 100 mg/day [8]. The American Headache Society's 2021 consensus statement lists all of these medications as appropriate first-line options depending on attack frequency and patient comorbidities [9].

Cove's Trustpilot profile shows approximately 3,600 reviews with a 4.2/5 average. Positive reviews highlight prescription access without a neurologist referral, which in many US markets involves a 3 to 6 month wait. Dr. Andrew Charles, director of the UCLA Goldberg Migraine Program, has noted: "For patients with straightforward episodic migraine, a primary care level evaluation is appropriate for initiating first-line treatments. Specialist referral becomes important when patients fail two or more preventive medications or have atypical features" [9].

The main criticisms in Cove reviews involve insurance coordination. Cove prescriptions ship directly and are often paid out-of-pocket, bypassing insurance. For generic sumatriptan (approximately $1 per tablet at retail pharmacies with GoodRx), this may not matter. For branded drugs like Nurtec ODT (list price roughly $900/month), the cost difference is significant. Several reviewers reported being unaware they could fill a Cove prescription at a local pharmacy using insurance benefits until after multiple out-of-pocket shipments.

Thirty Madison vs. Competitors: A Direct Comparison

The direct-to-consumer telehealth market for hair loss and migraine includes Hims & Hers, Ro (Roman), Lemonaid Health, and PlushCare. Meaningful differences exist across five dimensions.

Consultation model. Keeps and Cove use asynchronous review. Hims offers both asynchronous and synchronous options depending on the condition. Ro (Roman) uses asynchronous intake with optional follow-up calls. PlushCare requires live video for all visits.

Pricing for finasteride 1 mg (30-day supply). Keeps charges approximately $25/month on a quarterly plan. Hims charges $23 to $30/month. Ro charges $20/month. GoodRx retail price at a local pharmacy is $9 to $15 for generic finasteride without insurance. The branded version (Propecia) lists at $70 to $90/month, though few prescribers use it given generic equivalence.

Pricing for sumatriptan 100 mg (9 tablets). Cove charges approximately $45 to $55 per shipment. GoodRx price at retail pharmacy: $12 to $25 for 9 tablets of generic sumatriptan.

Provider credentials. All four platforms use licensed physicians, nurse practitioners, or physician assistants depending on the state. None of the platforms publicly report the proportion of consultations handled by physicians versus mid-level providers. A 2022 JAMA Network Open analysis of prescribing patterns across telehealth platforms found no clinically significant differences in guideline adherence between physician and NP-led telehealth encounters for common conditions including alopecia [10].

Bundling. Keeps sells multi-product kits (finasteride + minoxidil + ketoconazole shampoo) at discounted bundle pricing. Hims similarly bundles, often including sildenafil across categories. Thirty Madison's structure keeps each condition siloed under its own brand, which means a patient using Keeps and Cove maintains two separate accounts, two separate provider relationships, and two separate billing cycles.

The Legitimacy Question: Is Thirty Madison a Real Medical Service?

Yes. Thirty Madison operates through licensed prescribers in each state where it provides services. Keeps, Cove, Picnic, and Facet prescriptions are written by clinicians credentialed through state medical boards and dispensed by licensed pharmacies.

The company holds an A+ rating with the Better Business Bureau. It is not listed in the FDA's database of warning letters to online pharmacies. The medications dispensed are FDA-approved generics or branded drugs purchased through legitimate pharmaceutical supply chains.

The concern some patients raise is valid in a different sense. Asynchronous telehealth for conditions that could signal more serious pathology carries risk. Diffuse hair thinning in a 28-year-old male is almost certainly androgenetic alopecia. Diffuse hair thinning in a 45-year-old woman could indicate thyroid dysfunction, iron deficiency, or autoimmune alopecia, each requiring blood work and a different treatment pathway [11]. Thirty Madison's intake questionnaires include screening questions for red-flag symptoms, but the asynchronous format limits a provider's ability to probe ambiguous answers.

The American Medical Association's 2024 telehealth policy guidelines recommend that "telehealth encounters for new prescriptions should include sufficient clinical evaluation to establish a diagnosis, which may require synchronous interaction for conditions with broad differential diagnoses" [12]. Pattern-recognition conditions like typical male androgenetic alopecia fall within the lower-risk category. Migraine with aura, which can mimic stroke or other vascular events, sits higher on the evaluation complexity scale.

What Thirty Madison Prescribes: Full Formulary Breakdown

Thirty Madison is not a compounding pharmacy and does not sell proprietary blends. Everything prescribed is an FDA-approved medication. Here is the documented formulary across brands:

Keeps (androgenetic alopecia):

• Finasteride 1 mg oral tablet (generic Propecia)
• Minoxidil 5% topical solution or foam (generic Rogaine)
• Ketoconazole 2% shampoo (adjunctive, not FDA-approved for alopecia specifically)
• Biotin supplements (OTC, sold as add-on)

Cove (migraine):

• Acute: sumatriptan, rizatriptan, ubrogepant (Ubrelvy), rimegepant (Nurtec ODT)
• Preventive: topiramate, propranolol, amitriptyline, metoprolol
• Device: Cefaly external trigeminal nerve stimulator (available through Cove's online store)

Picnic (allergic rhinitis):

• Fluticasone nasal spray
• Azelastine nasal spray
• Cetirizine, loratadine, or fexofenadine (oral antihistamines)
• Montelukast (by prescription, with FDA black-box warning counseling)

Facet (dermatology):

• Tretinoin 0.025% to 0.1% cream
• Clindamycin 1% topical
• Azelaic acid 15% gel
• Niacinamide formulations (OTC tier)

None of these medications are experimental or off-label in surprising ways. The one exception worth flagging: montelukast (Singulair) carries an FDA boxed warning for neuropsychiatric events including suicidal ideation, and the FDA's 2020 advisory explicitly states it should not be first-line for allergic rhinitis [13]. Picnic's intake process should screen for mood disorders before prescribing montelukast, though it is unclear from public materials how rigorously this screening is enforced in the asynchronous format.

Cost Analysis: When Thirty Madison Makes Financial Sense

Thirty Madison's pricing is competitive for uninsured patients but often more expensive than using insurance at a retail pharmacy.

For a patient without insurance paying cash, Keeps' quarterly finasteride plan ($75 for 90 days, or $25/month) compares reasonably to GoodRx's best retail price of $9 to $15/month for the same generic. The convenience premium is roughly $10 to $16 per month. For patients with prescription insurance, the copay for generic finasteride is typically $0 to $10, making Keeps materially more expensive.

The value proposition shifts for patients who lack a primary care provider or face long wait times. A new-patient PCP visit costs $150 to $350 out-of-pocket, and a dermatology consult runs $200 to $450 in most markets. If a patient needs the prescription but not the physical exam (which is the case for textbook androgenetic alopecia in young men), the Keeps model saves the office visit fee.

Cove's value equation depends heavily on which medication is prescribed. For generic triptans, retail pharmacy pricing almost always beats Cove's direct-ship model. For CGRP inhibitors like Nurtec ODT, manufacturer copay assistance programs (available at Nurtec's official site) may bring costs below Cove's cash price, but navigating these programs takes time. Cove removes that administrative burden.

Long-Term Adherence and Outcomes Data

The biggest predictor of treatment success for both finasteride and migraine preventives is adherence. A retrospective pharmacy claims analysis published in the Journal of the American Academy of Dermatology found that only 36% of men prescribed finasteride remained on therapy at 12 months [14]. The subscription model used by Keeps and similar platforms may improve this. Automatic refills eliminate the friction of calling in refills or visiting a pharmacy.

No peer-reviewed study has directly compared adherence rates between traditional pharmacy fulfillment and D2C telehealth subscription models for finasteride specifically. This is a gap in the literature. The closest analogy comes from hypertension management, where a 2021 randomized trial found that mail-order pharmacy with automatic refills improved medication possession ratios by 6.2 percentage points versus standard retail fills [15].

For migraine preventives, the picture is similar. Topiramate discontinuation rates reach 40 to 50% within 6 months, primarily due to cognitive side effects ("brain fog," word-finding difficulty) and paresthesias [8]. No telehealth platform, including Cove, has published data showing their model reduces these discontinuation rates. The side effects are pharmacologic, not logistic. Easier refills cannot solve them.

Safety Considerations and Red Flags to Watch

Thirty Madison's platforms are legitimate, but three safety considerations deserve attention from prospective patients.

Drug interactions. Asynchronous intake forms rely on patient self-reporting of current medications. A patient who forgets to list an SSRI may receive a triptan prescription without adequate screening for serotonin syndrome risk. The absolute risk is low (the FDA's Adverse Event Reporting System shows roughly 0.03 serotonin syndrome reports per 1,000 triptan prescriptions when co-administered with SSRIs [7]), but it is a non-zero risk that synchronous encounters can catch through conversation.

Monitoring gaps. Finasteride can affect PSA levels, reducing them by approximately 50% [5]. Men over 40 using Keeps should ensure their primary care provider knows they are taking finasteride so PSA screening results are interpreted correctly. Keeps' intake process asks about age and prostate history, but the asynchronous format may not sufficiently emphasize this interaction for patients without a PCP.

Diagnostic limitations. A 2024 systematic review in Telemedicine and e-Health found that asynchronous teledermatology had a 12% rate of clinically significant diagnostic discordance (cases where the asynchronous diagnosis differed meaningfully from in-person evaluation) [1]. For hair loss specifically, the rate was lower at 5 to 7%, since androgenetic alopecia has a characteristic pattern that photographs capture well.

The bottom line: Thirty Madison works best for patients with straightforward, previously diagnosed conditions who need convenient prescription access. Patients with complex, multi-system symptoms or atypical presentations should start with an in-person evaluation. Generic finasteride costs $0.30 to $0.50 per day regardless of where it is prescribed.